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ABSTRACT:!Neuroblastoma$is$one$of$the$most$common$and$deadly$childhood$cancers.$Neuroblastoma$arises$ from$ transformed$ cells$ of$ the$neural$ crest$ lineage.$Outcomes$of$the$ disease$ vary$ greatly,$ ranging$ from$ spontaneous$ regression$ to$ aggressive$metastases[1$ 2].$While$ this$ variability$may$ reflect$ the$ inherent$migratory$ capabilities$and$multipotency$of$neural$crest$cells,$there$have$been$few$direct$comparisons$between$neuroblastoma$and$embryonic$neural$ crest$ cells,$ in$part$because$of$ the$ limited$ in(vivo(accessibility$of$ the$mammalian$neural$ crest$ lineage.$Our$ recent$ studies$demonstrate$a$novel$ link$between$anaplastic$ lymphoma$kinase$(ALK)$and$glycogen$synthase$kinase$3$(GSK3).$ Our$ work$ suggests$ that$ ALKZdependent$ regulation$ of$ GSK3$ via$ tyrosine$phosphorylation$may$alter$the$substrate$specificity$of$GSK3,$thus$regulating$cytoskeletal$dynamics$in$migrating$neural$crest$cells.$
!
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Neural(crest(origins(of(neuroblastoma:(Neuroblastoma,$one$of$ the$most$ common$paediatric$ solid$ tumors,$ is$ thought$ to$arise$ from$ multipotent$ neural$ crest$ cells,$ which$ give$ rise$ to$ a$ variety$ of$ cell$ types$including$the$sympathetic$nervous$system.$Indeed,$simply$forcing$expression$of$NZMyc$in$neural$crest$cells$(NCCs)$is$sufficient$to$drive$a$neuroblastomaZlike$phenotype[2].$The$prognosis$appears$linked$to$the$differentiation$status$of$the$cells.$When$the$tumor$cells$are$ relatively$undifferentiated,$ the$prognosis$ is$poor.$ Inducing$differentiation$ towards$neuronal$lineages$through$the$therapeutic$use$of$retinoic$acid$is$sometimes$an$effective$cure[3].$ This$ similarity$ to$ naïve,$ multipotent,$ embryonic$ neural$ crest$ cells$ sets$ up$ a$model$where$neuroblastoma$is$the$result$of$the$delay$or$blockade$of$the$developmental$progression$of$the$neural$crest$lineage.$$We$have$some$understanding$of$activation$mutations$ in$neuroblastoma[4].$One$of$the$key$factors$is$anaplastic$lymphoma$kinase$(ALK),$a$multifaceted$tyrosine$kinase.$Prior$to$our$work,$ALK$had$not$been$functionally$analyzed$ in$neural$crest$cells.$ In$our$recent$ work,$ we$ directly$ compared$ embryonic$ neural$ crest$ cells$ with$ a$ panel$ of$neuroblastoma$cells[5].$We$found$that$ALK$is$indeed$expressed$in$the$embryonic$neural$crest$and$that$the$activity$of$ALK$is$parallel$to$the$activation$of$GSK3,$another$pleiotropic$kinase,$which$ is$required$at$multiple$steps$ in$neural$crest$development[6$7].$Based$on$our$ data,$ we$ hypothesized$ that$ ALK$may$ regulate$ GSK3$ by$ tyrosine$ phosphorylation$during$normal$neural$crest$development$and$that$dysregulation$of$ this$kinase$cascade$might$underlie$the$pathology$of$neuroblastoma.$
(
ALK(interactions(in(neuroblastoma:(Activating$ mutations$ in$ the$ ALK$ oncogene$ are$ among$ the$ leading$ causes$ for$hereditary$ NB.$ These$ mutations$ are$ somatically$ acquired$ in$ approximately$ 10%$ of$sporadic$ cases$ of$ neuroblastoma;$ thus,$ ALK$ has$ been$ considered$ as$ a$ potential$treatment$target[8].$The$most$common$mutations$found$are$F1174L$and$R1275Q;$both$lie$ within$ the$ ALK$ kinase$ domain.$ These$ mutations$ lead$ to$ ligandZindependent$ autoZphosphorylation$ of$ ALK$ and$ increased$ kinase$ activity$ when$ compared$ to$ wildZtype$
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Page 3 of 9(ALK[9$ 10].$ Activation$ of$ ALK$ in$ neuroblastoma$ is$ normally$ associated$ with$ poor$prognosis,$ contributing$ to$ increased$ cell$ proliferation,$ survival$ and$ migration.$Interestingly,$ some$ studies$ have$ reported$ a$ close$ association$ of$ ALK$ with$ NZMYC$amplification,$ although$ the$ links$ are$ unclear.$ This$ association$ has$ been$ related$ to$aggressive$and$metastatic$neuroblastoma[11],$presumably$via$a$model$in$which$the$cells$are$prevented$from$differentiating.$ $However,$in$other$studies,$this$correlation$was$not$confirmed;$ therefore,$ the$possibility$of$synergy$between$these$two$oncogenes$remains$questionable[12];$thus,$alternative$links/effects$should$be$explored.$$$
Regulation(of(GSK3(activity(is(complex:(GSK3$ proteins$ are$ highly$ abundant$ cellular$ kinases$ reported$ to$ have$ many$substrates.$In$vertebrates,$GSK3$proteins$are$encoded$by$two$genes,$GSK3α$and$GSK3β,$which$ differ$ in$ the$ nZ$ and$ cZterminal$ domains$ but$ are$ nearly$ identical$ in$ the$ kinase$domain.$While$GSK3$is$thought$to$be$constitutively$active$in$resting$cells,$it$is$clear$that$GSK3$ activity$ levels$ can$ be$ dependent$ on$ phosphorylation$ of$ residues$ on$ GSK3$ itself.$Inactivation$ of$ GSK3$ can$ occur$ via$ phosphorylation$ of$ NZterminal$ serines$ (S21$ on$GSK3α,$ S9$ on$ GSK3β).$ This$ results$ in$ the$NZterminus$ acting$ as$ a$ pseudosubstrate$ for$GSK3.$ When$ phosphorylated,$ the$ NZterminus$ blocks$ access$ of$ other$ potential$ GSK3$substrates.$ However,$ as$mice$ carrying$ nonZphosphorylatable$ GSK3$ variants$ (in$which$S21/S9$ are$ mutated$ to$ alanines[13])$ can$ still$ be$ inhibited$ in$ the$ context$ of$ Wnt$signaling,$there$must$be$alternative$mechanisms$of$GSK3$regulation.$Briefly,$ GSK3$ is$ one$ component$ of$ the$ "destruction$ complex"$ of$ βZcatenin,$ an$effector$protein$of$Wnt$signaling.$In$resting$cells,$this$complex$remains$in$its$active$form$in$which$GSK3,$along$with$other$kinases,$phosphorylates$βZcatenin.$Phosphorylated$βZcatenin$ is$ then$ubiquitinated$and$ targeted$ for$proteasomal$degradation.$ $On$ the$other$hand,$ in$ response$ to$Wnt$ signals,$ the$ cells$ respond$ by$ disassembling$ the$ destruction$complex.$GSK3$is$no$longer$active$and$cannot$phosphorylate$βZcatenin$due$to$a$ loss$of$physical$proximity.$As$βZcatenin$accumulates$in$the$cytosol,$it$can$then$be$translocated$to$the$nucleus$to$activate$transcriptional$targets.$One$possibility$is$that$dedicated$pools$of$GSK3$exist$within$the$cell,$likely$in$complex$with$different$partner$proteins,$and$that$these$pools$of$GSK3$can$be$activated$or$ inactivated$ independently.$Thus,$ regulation$of$GSK3$is$clearly$more$complicated$than$a$simple$inhibitory$phosphorylation.$
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Positive(regulation(of(GSK3(via(ALK(tyrosine(kinase:(Because$ the$ presumption$ is$ that$ GSK3$ proteins$ are$ “constitutively”$ active,$positive$regulatory$mechanisms$have$been$understudied.$We$have$known$for$some$time$that$GSK3$proteins$can$exist$in$a$tyrosine$phosphorylated$form$(pYZGSK3:$Y216/GSK3α$and$Y279/GSK3β).$Because$it$has$been$shown$that$these$phosphates$can$be$added$via$an$autoZphosphorylation$ event,$ pYZGSK3$ has$ generally$ been$ accepted$ as$ an$ indication$ of$“active”$ GSK3.$ However,$ a$ recent$ study$ proposed$ that$ pYZGSK3$ proteins$ are$ instead$“hyperactive”$and$ that$phosphorylation$at$ these$residues$changes$ the$conformation$of$the$ active$ site$ in$ both$ the$ GSK3α$ and$ GSK3β$ kinase$ domains[14].$ This$ change$ in$conformation$ would$ change$ the$ binding$ interactions$ with$ putative$ GSK3$ substrates,$raising$the$possibility$that$this$is$a$previously$unappreciated$level$of$regulation.$$While$it$is$clear$that$GSK3$can$autophosphorylate$these$tyrosine$residues,$GSK3$is$itself$a$serine/threonine$kinase,$so$it$seems$more$likely$that$there$is,$instead,$a$cellular$tyrosine$kinase$that$ takes$on$this$role$during$normal$GSK3$regulation.$ALK$is$a$strong$candidate$for$being$this$kinase.$In$a$computational$study$for$predicted$substrates$of$ALK$in$neuroblastoma$cell$ lines,$GSK3α$was$ identified$as$a$potential$ target[15].$Therefore,$we$decided$to$survey$both$neural$crest$and$neuroblastoma$lines$in$parallel$to$determine$whether$there$was$any$link$between$ALK$and$GSK3.$$
Localisation(of(active(ALK(and(active(GSK3(during(a(crucial(step(in(NC(delamination:(In$our$work,$we$found$that$both$ALK$and$pYZGSK$are$expressed$in$delaminating$and$ migrating$ neural$ crest$ cells.$ ALK$ expression$ in$ the$ mouse$ embryo$ had$ not$previously$been$ studied$ in$ these$ cells.$ Interestingly,$we$ found$ it$ expressed$during$ the$precise$stages$of$embryonic$development,$from$8.5dpc,$when$the$cranial$neural$crest$is$actively$ migrating.$ Specifically,$ we$ found$ that$ ALK$ coZexpresses$ with$ pYZGSK3$ in$ the$right$place$at$the$right$time$to$be$controlling$neural$crest$delamination$and$subsequent$cell$ migration.$ More$ specifically,$ we$ found$ that$ in$ delaminating$ cells,$ pYZGSK3$ is$expressed$at$the$cell$side$facing$towards$the$direction$of$migration,$and$active$ALK$is$coZexpressed$in$these$cells.$$
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Page 5 of 9(Using$pharmacological$ inhibitors$of$ALK,$ including$several$used$in$the$clinic$ for$chemotherapy,$we$ found$ that$we$ could$ block$ neural$ crest$ delamination.$ Inhibition$ of$GSK3,$either$genetically$or$pharmacologically,$led$to$similar$results.$Moreover,$we$found$that$inhibition$of$ALK$led$to$a$loss$of$expression$of$the$phosphoZtyrosine$form$of$GSK3.$Thus,$in$mammalian$neural$crest$cells$ALK$is$implicated$in$the$tyrosine$phosphorylation$of$GSK3$leading$to$a$loss$of$cell$migration.$$$$
Neuroblastoma(lines(with(high(levels(of(ALK(also(have(high(levels(of(activated(GSK3:(The$ molecular$ profiles$ of$ neuroblastoma$ are$ remarkably$ heterogeneous$ and$there$ have$ been$ efforts$ to$ use$ these$ profiles$ to$ refine$ prognoses.$ As$ the$ clinical$outcomes$can$range$from$spontaneous$regression$to$a$highly$lethal$metastatic$disease,$additional$insights$into$the$molecular$profiles$are$important.$Therefore,$in$parallel$with$a$ neural$ crest$ model,$ we$ set$ out$ to$ determine$ whether$ high$ levels$ of$ ALK$ in$neuroblastoma$correlated$with$active$pYZGSK3.$We$can$hypothesize$that$certain$types$of$neuroblastoma$reflect$specific$phases$in$the$development$of$neural$crest$cells.$From$ the$ neuroblastoma$ lines$ that$ we$ analysed,$ we$ found$ a$ clear$ association$between$the$expression$of$ALK$and$tyrosine$phosphorylation$of$GSK3.$These$cell$ lines$included$ ones$ that$ were$ genetically$ mutated$ such$ as$ the$ Kelly$ line$ that$ carries$ the$F1174L$ activating$mutation,$ as$ well$ as$ lines$ with$ elevated$ levels$ of$ ALK$ due$ to$ nonZgenetic$causes.$We$found$that$the$subset$of$NB$cell$ lines$expressing$high$levels$of$ALK$also$exhibited$high$levels$of$pYZGSK3.$Conversely,$the$NB$cell$lines$that$showed$minimal$ALK$expression$(e.g.,$LS$line)$did$not$express$pYZGSK3.$$
GSK3(inhibition(can(block(cell(migration(in(“high(ALK”(neuroblastoma(lines:(To$ test$whether$GSK3$phosphorylation$was$ downstream$of$ ALK$ activity$ in$ the$neuroblastoma$ lines,$ we$ used$ scratch$ assays$ where$ we$ block$ GSK3$ activity$ using$pharmacological$ inhibitors.$We$first$assessed$the$Kelly$line.$As$noted,$the$Kelly$NB$cell$line$is$well$characterized$and$is$known$to$carry$an$activating$ALK$mutation$(F1174L)$as$well$as$amplification$of$NZMYC.$Based$on$our$knowledge$of$the$developmental$program$of$ neural$ crest$ cells,$ this$ combination$ of$ factors$ (ALK$ and$ MYC)$ would$ suggest$ an$
Gonzalez(Malagon(&(Liu(
Page 6 of 9(analogy$between$Kelly$cells$and$neural$crest$cells$just$at$the$cusp$of$migration.$Indeed,$inhibition$of$GSK3$led$to$a$block$in$neural$crest$migration$and$Kelly$NB$line.$In$ contrast,$ the$ LS$ NB$ cell$ line$ does$ not$ carry$ an$ activating$ mutation$ of$ ALK.$Application$ of$ GSK3$ inhibitors$ led$ to$ a$ very$ surprising$ response$ in$ LS$ cells,$ which$formed$aggregates$and$showed$an$ increase$ in$apoptosis.$Closer$examination$of$ the$LS$cells$suggested$that,$when$cultured,$these$cells$behaved$more$like$pseudoZepithelial$cells$rather$than$fully$mesenchymal$cells.$Taken$together,$we$propose$that$LS$and$Kelly$lines,$if$ superimposed$ on$ the$ neural$ crest$ developmental$ clock,$ are$ not$ at$ the$ same$developmental$ phase.$ It$ seems$ likely$ that$ the$ LS$ cells$ are$ more$ analogous$ to$premigratory$ neural$ crest$ cells$ while$ the$ Kelly$ cells$ represent$ a$ more$ migratory$mesenchymal$population.$It$would$be$interesting$to$study$more$NB$cells$with$different$molecular$backgrounds$to$understand$better$if$the$behavioral$outcome$of$NB$represents$a$specific$stage$of$neural$crest$development$where$aggressive,$metastatic$tumors$behave$similarly$to$the$migratory$neural$crest$population.$$$$
ALK(regulates(GSK3(in(migratory(neural(crest,(but(not(during(neural(crest(induction.(By$using$primary$neural$crest$explants,$we$were$able$to$assess$the$effect$of$ALK$and$ GSK3$ inhibition$ on$ the$ following$ populations:$ neural$ plate$ cells,$ newly$ induced$premigratory$(epithelial)$cells,$and$migratory$(mesenchymal)$cells.$ In$these$assays,$we$found$that$inhibition$of$GSK3$led$to$an$increase$in$the$area$occupied$by$the$premigratory$population$and$a$decrease$ in$the$migratory$populations.$However,$ALK$inhibition$only$significantly$affected$ the$migratory$population.$This$suggests$ that$while$ALK$regulates$GSK3$ activity$ in$ the$ migratory$ population,$ GSK3$ has$ an$ independent$ function$ in$ the$premigratory$neural$crest.$This$premigratory$function$is$most$likely$related$to$the$role$of$ GSK3$ in$Wnt$ signaling,$ as$ others$ have$ shown$ that$ GSK3$ inhibition$ upregulates$ βZcatenin$ activity$ leading$ to$ an$ expansion$ of$ neural$ crest$ induction[16$ 17],$ while$subsequent$downZregulation$of$Wnt$is$necessary$for$neural$crest$migration[18$19].$All$ together,$ our$ work$ identifies$ a$ new$ role$ for$ ALK,$ the$ regulation$ of$ GSK3$during$normal$and$pathological$development$of$the$neural$crest.$Further$studies$should$focus$on$the$contextual$regulation$of$these$two$important$kinases$and$the$potential$for$GSK3$inhibition$in$the$treatment$of$neuroblastoma.$
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